After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
Stocks Info
NewAmsterdam Pharma Company NV is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Biotechnology industry. The current market capitalization of NewAmsterdam Pharma Company NV is $2.26B. A total of 1.0 million shares were traded on the day, compared to an average of 947.10K shares.
In the most recent transaction, Douglas F Kling bought 298,612 shares of NAMS for 18.75 per share on May 15 ’25. In a previous transaction on Apr 11 ’25, NAP PoolCo B.V. bought 1,433,193 shares at 15.12 per share.
Among the insiders who bought shares, Topper James N acquired of 1,135 shares on Mar 26 ’25 at a per-share price of $22.49. This resulted in the Director holding 3,013,569 shares of NAMS after the transaction. In another insider transaction, Michael H. Davidson bought 12,258 shares at $23.41 per share on Mar 26 ’25.
Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. In terms of 52-week highs and lows, NAMS has a high of $27.29 and a low of $14.06.
As of this writing, NAMS has an earnings estimate of -$0.43 per share for the current quarter. EPS was calculated based on a consensus of 9.0 estimates, with a high estimate of -$0.37 per share and a lower estimate of -$0.49.
Balance Sheet Annually/Quarterly
A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. NAMS’s latest balance sheet shows that the firm has $60.11M in Cash & Short Term Investments as of fiscal 2021. There were $185.68k in debt and $11.19M in liabilities at the time. Its Book Value Per Share was $6.93, while its Total Shareholder’s Equity was $56.37M.
Analysts Opinion
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for NAMS is Buy with a score of 4.80.
